Basic Information
| LncRNA/CircRNA Name | LINC-ROR |
| Synonyms | LINC-ROR, ROR, lincRNA-RoR |
| Region | GRCh38_18:57054558-57072119 |
| Ensemble | ENSG00000258609 |
| Refseq | NR_048536 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | gastric cancer |
| ICD-0-3 | C16 |
| Methods | RT-PCR, Western blot |
| Sample | gastric cancer tissues,cell lines |
| Expression Pattern | up-regulated |
| Function Description | Depletion of ROR reduced MRP1 expression and increased apoptosis of drug-resistant gastric cancer cells in response to ADR and VCR treatment. |
| Pubmed ID | 32019330 |
| Year | 2020 |
| Title | lncRNA ROR Promotes Gastric Cancer Drug Resistance |
External Links
| Links for LINC-ROR | GenBank HGNC NONCODE |
| Links for gastric cancer | OMIM COSMIC |